Last week we posted about the publication of a new manual for therapists engaged in providing cognitive behavioural therapy to people with learning disabilities . In that post, we drew attention to two randomised trials that had been done in the early 2000’s whose findings were m anger – encouraging. This latest study adds a [read the full story…]
The MATISSE trial in 2012 concluded that group art therapy did no better than standard care at improving symptoms for people with schizophrenia. A new critique of that RCT from the British Association of Art Therapists says the therapy can be more useful.
[read the full story...]
Alex Langford summarises a relatively large and pragmatic study, which provides firm evidence that the newer antipsychotic, Paliperidone, is no better at preventing relapse or controlling psychotic symptoms than its decades-old comparator, Haloperidol.
[read the full story...]
There are many interfaces in mental health services, such as the one between physical and mental health. Where there are interfaces, there are inevitably gaps for patients to fall through. Consequently opportunities are missed to treat mental health problems in those with physical health problems. There is mounting evidence for the effectiveness of Collaborative Care (CC) [read the full story…]
I had actually heard about this Danish study, published recently by Poulsen et al. (2014) in the American Journal of Psychiatry, before it landed in my inbox. The findings are interesting because they highlight the debate surrounding the comparative efficacy of psychological treatments. What is most striking though, is how the study itself challenges the [read the full story…]
In addition to its impact on quality of life, panic disorder can have a number of costly consequences such as lost productivity – particularly if also associated with agoraphobia. Cost-effectiveness is therefore an important consideration in choosing the optimal treatment for panic disorder, which might improve value via the cost side of the equation. A recent [read the full story…]
Approximately 10.6% of individuals with Substance Use Disorders (SUD) in the US seek treatment, with 40-60% relapsing within a year (Dept of Health and Human Services, 2008; McLellan et al, 2000). This highlights a real need for substance abuse treatment that focuses on relapse prevention. This blog summarises a recent RCT from JAMA Psychiatry on [read the full story…]
Anorexia Nervosa (AN) is a very serious illness with a high morbidity; it is also notoriously difficult to treat. Praise then to researchers investigating innovative treatments that might help. This pair of papers investigating the hormone oxytocin have been widely reported in the popular press, from the BBC to Time magazine and the Daily Mail (link withheld [read the full story…]
If a treatment is powerful enough to have a good effect, then it’s powerful enough to have a bad effect. This is well recognised when it comes to medication, with strict regulations in place to ensure adverse outcomes are monitored and measured. By contrast, psychotherapy has never been as readily associated with the potential to [read the full story…]
The link between external influences such as family and neighbourhood experiences and young people’s mental health outcomes has been extensively commented on in the literature. While it is more common for studies to focus on the individual or family level, looking at things from a wider perspective is interesting especially from a public mental health [read the full story…]
